<?xml version="1.0" encoding="UTF-8"?>
<ref id="b51-etm-0-0-8096">
 <label>51</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Pilling</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Gomer</surname>
    <given-names>RH</given-names>
   </name>
  </person-group>
  <article-title>The development of serum amyloid P as a possible therapeutic</article-title>
  <source>Front Immunol</source>
  <volume>9</volume>
  <fpage>2328</fpage>
  <year>2018</year>
  <pub-id pub-id-type="doi">10.3389/fimmu.2018.02328</pub-id>
  <?supplied-pmid 30459752?>
  <pub-id pub-id-type="pmid">30459752</pub-id>
 </element-citation>
</ref>
